Buscar
05/09/2022
Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI
Vogel, RF, Delewi, R, Badimon, L, Angiolillo, DJ, Vlachojannis, GJ. Current Status and Future Direction of Antithrombotic Therapy for Patients with STEMI Undergoing Primary PCI. Reviews in Cardiovascular Medicine. 2022; 23(9)DOI:10.31083/j.rcm2309297. PMID:. IF:2.700(Q3/6D).
01/01/2022
Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio
Radike M., Ben-Aicha S., Gutiérrez M., Hidalgo A., Badimón L., Vilahur G.. Comparación de dos programas de posprocesamiento de imágenes de cardiorresonancia magnética en un modelo porcino de infarto de miocardio. REVISTA ESPANOLA DE CARDIOLOGIA. 2022; 76(2)DOI:10.1016/j.recesp.2022.06.007. PMID:35809893. IF:5.900(Q1/3D).
01/01/2022
European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment
Lee G.A., Aktaa S., Baker E., Gale C.P., Yaseen I.F., Gulati G., Asteggiano R., Szmit S., Cohen-Solal A., Abdin A., Jurczak W., Garrido Lopez P., Sverdlov A.L., Tocchetti C.G., Barac A., Parrini I., Zamorano P., Iakobishvili Z., Pudil R., Badimon L., Kirby A.M., Blaes A.H., Farmakis D., Curigliano G., Stephens R., Lyon A.R., Lopez-Fernandez T.. European Society of Cardiology quality indicators for the prevention and management of cancer therapy-related cardiovascular toxicity in cancer treatment. European Heart Journal-Quality of Care and Clinical Outcomes. 2022; 9(1)DOI:10.1093/ehjqcco/qcac070. PMID:36316010. IF:5.200(Q2/3D).
01/01/2022
Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients
Pérez de Isla L., Alonso R., Argüeso R., Muñiz-Grijalvo O., Álvarez-Baños P., Badimón L., Watts G.F., Mata P.. Predicting resilience in heterozygous familial hypercholesterolaemia: A cohort study of octogenarian patients. Journal of Clinical Lipidology. 2022; 16(5)DOI:10.1016/j.jacl.2022.07.007. PMID:35906178. IF:4.400(Q2/3D).